The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Baseline ocular conditions and risk of ocular events in patients (pts) with relapsed/refractory multiple myeloma (RRMM) from the DREAMM-7 and DREAMM-8 trials of belantamab mafodotin (belamaf).
 
Meral Beksac
Consulting or Advisory Role - BMS Turkey (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Oncopeptides (Inst); Pfizer (Inst); Sanofi (Inst); Takeda (Inst)
Speakers' Bureau - BMS Turkey (Inst); Menarini (Inst); Sanofi (Inst); Takeda (Inst)
 
Hang Quach
Consulting or Advisory Role - Antengene (Inst); Bristol-Myers Squibb/Celgene; GlaxoSmithKline (Inst); Janssen-Cilag; Karyopharm Therapeutics (Inst); Pfizer; Roche; Sanofi (Inst)
Research Funding - Amgen; Bristol-Myers Squibb/Celgene; Celgene; GlaxoSmithKline; Karyopharm Therapeutics; Sanofi
 
Vania Hungria
Consulting or Advisory Role - Abbvie; Amgen; BMS Brazil; GlaxoSmithKline; Janssen-Cilag; Pfizer; Regeneron; Sanofi; Takeda
Speakers' Bureau - Abbvie; Amgen; BMS Brazil; GlaxoSmithKline; Janssen-Cilag; Pfizer; Sanofi; Takeda
 
Ludek Pour
No Relationships to Disclose
 
Kihyun Kim
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; GlaxoSmithKline; Johnson & Johnson
Research Funding - Bristol-Myers Squibb; Johnson & Johnson; Sanofi
 
Sergey Voloshin
Speakers' Bureau - Abbvie; AstraZeneca; Janssen; Novartis; Sanofi
 
Hanlon Sia
No Relationships to Disclose
 
Esther Gonzalez
No Relationships to Disclose
 
Chang-Ki Min
No Relationships to Disclose
 
Marcelo Pitombeira de Lacerda
Honoraria - Abbvie; AstraZeneca; Beigene; GlaxoSmithKline; Janssen
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Roche; Viracta Therapeutics
 
Anna Sureda
No Relationships to Disclose
 
Ivan Spicka
Honoraria - Amgen; Bristol-Myers Squibb; Janssen-Cilag; Sanofi; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Janssen-Cilag; Sanofi; Takeda
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Janssen-Cilag; Sanofi
 
Marek Hus
No Relationships to Disclose
 
Vera Zherebtsova
No Relationships to Disclose
 
Margaret Polinkovsky
Employment - GlaxoSmithKline
 
Sybil Varghese
Employment - GlaxoSmithKline
 
Joe Lee
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Elisabet Manasanch
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Pawel Robak
No Relationships to Disclose
 
Meletios Dimopoulos
Honoraria - Amgen; AstraZeneca; Beigene; Bristol-Myers Squibb; GlaxoSmithKline; Janssen-Cilag; Menarini; Regeneron; Sanofi; Swixx BioPharma; Takeda
Consulting or Advisory Role - Amgen; AstraZeneca; Beigene; Bristol-Myers Squibb; GlaxoSmithKline; Janssen-Cilag; Menarini; Regeneron; Sanofi; Swixx BioPharma; Takeda
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb/Celgene; Janssen; Takeda